カテゴリ： , , MarketLine

Alexion Pharmaceuticals, Inc.

◆英語タイトル：Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY3503
◆発行会社（調査会社）：MarketLine
◆発行日：2019
◆ページ数：54
◆レポート言語：
◆レポート形式：PDF
◆納品方法：E
◆対象地域：
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site LicenseUSD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide LicenseUSD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Alexion Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Alexion Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Alexion Pharmaceuticals, Inc. (Alexion or ‘the company’) is a biopharmaceutical company involved in the innovation, development and commercialization of life-transforming therapeutic products. The company focuses on the therapeutic areas such as Hematology, Neurology, Nephrology and Metabolic disorders.Its product portfolio comprises Soliris (eculizumab) for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG); Strensiq (asfotase alfa) for the treatment of patients with hypophosphatasia; and Kanuma (sebelipase alfa) for the treatment of patients with lysosomal acid lipase deficiency. The company primarily operates in the US, Europe and Asia-Pacific. It is headquartered in New Haven, Connecticut, the US.

Scope

- Detailed information on Alexion Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Alexion Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Alexion Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Alexion Pharmaceuticals, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Alexion Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Alexion Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Alexion Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Alexion Pharmaceuticals, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Alexion Pharmaceuticals, Inc.: Company Overview
Alexion Pharmaceuticals, Inc.: Overview and Key Facts
Alexion Pharmaceuticals, Inc.: Overview
Alexion Pharmaceuticals, Inc.: Key Facts
Alexion Pharmaceuticals, Inc.: Key Employees
Alexion Pharmaceuticals, Inc.: Key Employee Biographies
Alexion Pharmaceuticals, Inc.: Major Products and Services
Alexion Pharmaceuticals, Inc.: Company History
Alexion Pharmaceuticals, Inc.: Management Statement
Alexion Pharmaceuticals, Inc.: Locations and Subsidiaries
Alexion Pharmaceuticals, Inc.: Key Competitors
Alexion Pharmaceuticals, Inc.: Company Analysis
Alexion Pharmaceuticals, Inc.: Business Description
Alexion Pharmaceuticals, Inc.: SWOT Analysis
Alexion Pharmaceuticals, Inc.: SWOT Overview
Alexion Pharmaceuticals, Inc.: Strengths
Alexion Pharmaceuticals, Inc.: Weaknesses
Alexion Pharmaceuticals, Inc.: Opportunities
Alexion Pharmaceuticals, Inc.: Threats
Alexion Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Alexion Pharmaceuticals, Inc.: Financial Deals Overview
Alexion Pharmaceuticals, Inc.: Targets and Partners
Alexion Pharmaceuticals, Inc.: Top Deals 2015 – 2019YTD*
Alexion Pharmaceuticals, Inc.: Advisors
Alexion Pharmaceuticals, Inc.: Top Legal Advisors
Alexion Pharmaceuticals, Inc.: Top Financial Advisors
Alexion Pharmaceuticals, Inc.: Mergers and Acquisitions
Alexion Pharmaceuticals, Inc.: Partnership
Alexion Pharmaceuticals, Inc.: Divestments
Alexion Pharmaceuticals, Inc.: Recent Developments
Alexion Pharmaceuticals, Inc.: News and Events Summary
Alexion Pharmaceuticals, Inc.: Contracts
Alexion Pharmaceuticals, Inc.: Corporate Governance
Alexion Pharmaceuticals, Inc.: Financial Deals
Alexion Pharmaceuticals, Inc.: Red Flags/DistressSignals
Alexion Pharmaceuticals, Inc.: Regulatory and Legal Events
Alexion Pharmaceuticals, Inc.: Research & Development
Alexion Pharmaceuticals, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Alexion Pharmaceuticals, Inc.: Key Facts
Table 2: Alexion Pharmaceuticals, Inc.: Key Employees
Table 3: Alexion Pharmaceuticals, Inc.: Company History
Table 4: Alexion Pharmaceuticals, Inc.: Locations and Subsidiaries
Table 5: Alexion Pharmaceuticals, Inc.: Key Competitors
Table 6: Alexion Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Alexion Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: Alexion Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Alexion Pharmaceuticals, Inc.: Targets and Partners
Table 10: Alexion Pharmaceuticals, Inc.: Top Deals 2015 - 2019YTD*
Table 11: Alexion Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Alexion Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Alexion Pharmaceuticals, Inc.: M&A Volume and Value Trend (2015 - YTD*2019)
Table 14: Alexion Pharmaceuticals, Inc.: M&A Activity by Geography (2015 - YTD*2019)
Table 15: Alexion Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 16: Alexion Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 17: Alexion Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 18: Alexion Pharmaceuticals, Inc.: News and Events Summary
Table 19: Alexion Pharmaceuticals, Inc.: Contracts
Table 20: Alexion Pharmaceuticals, Inc.: Corporate Governance
Table 21: Alexion Pharmaceuticals, Inc.: Financial Deals
Table 22: Alexion Pharmaceuticals, Inc.: Red Flags/DistressSignals
Table 23: Alexion Pharmaceuticals, Inc.: Regulatory and Legal Events
Table 24: Alexion Pharmaceuticals, Inc.: Research & Development
Table 25: Alexion Pharmaceuticals, Inc.: Strategy and Operations

★海外企業調査レポート[Alexion Pharmaceuticals, Inc.]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Aliancys AG：企業の戦略的SWOT分析
    Aliancys AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Esco Technologies Inc (ESE)：企業の財務・戦略的SWOT分析
    Esco Technologies Inc (ESE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Swisscom, Ltd.：企業の戦略・SWOT・財務情報
    Swisscom, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Swisscom, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • China Gezhouba Group Co Ltd (600068)：電力：M&Aディール及び事業提携情報
    Summary China Gezhouba Group Co Ltd (CGGC) is an engineering, procurement and construction (EPC) company. It provides a wide range of services including dredging, foundation works, building construction, engineering survey, designing, construction management and consultancy, and relevant technology …
  • InDex Pharmaceuticals Holding AB (INDEX)：企業の財務・戦略的SWOT分析
    Summary InDex Pharmaceuticals Holding AB (InDex Pharmaceuticals) is a pharmaceutical company that offers treatments for immunological diseases. The company’s lead compound cobitolimod, currently in the phase 2 stage, is intended for the treatment of moderate to severe treatment active refractory ulc …
  • sanofi-aventis US LLC-製薬・医療分野：企業M&A・提携分析
    Summary Sanofi-Aventis US LLC (Sanofi US), a subsidiary of Sanofi is a drug company that discovers, develops and distributes various therapeutic solutions. The company provides prescription products, vaccines and other products. Sanofi US’s vaccines include ActHIB, Adacel, DAPTACEL, Decavac, Fluzone …
  • Vesuvius Plc：企業の戦略・SWOT・財務情報
    Vesuvius Plc - Strategy, SWOT and Corporate Finance Report Summary Vesuvius Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Fluor Corporation (FLR)-エネルギー分野：企業M&A・提携分析
    Summary Fluor Corporation (Fluor) is a provider of engineering and construction services. The company's service portfolio includes design, engineering, procurement, fabrication, modularization, construction, commissioning and maintenance, and project management solutions. Fluor also offers other ser …
  • YFY Inc.：企業の戦略・SWOT・財務情報
    YFY Inc. - Strategy, SWOT and Corporate Finance Report Summary YFY Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • FleetCor Technologies, Inc.：企業のM&A・事業提携・投資動向
    FleetCor Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's FleetCor Technologies, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Electricidade de Mocambique EP：企業の戦略的SWOT分析
    Electricidade de Mocambique EP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • New Enterprise Associates Inc：企業のM&A・事業提携・投資動向
    New Enterprise Associates Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's New Enterprise Associates Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Alexion Pharmaceuticals, Inc.：企業の戦略・SWOT・財務分析
    Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Electricity Supply Board
    Electricity Supply Board - Strategy, SWOT and Corporate Finance Report Summary Electricity Supply Board - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Telekom Austria AG (TKA)：企業の財務・戦略的SWOT分析
    Telekom Austria AG (TKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Imbed Biosciences Inc：医療機器：M&Aディール及び事業提携情報
    Summary Imbed Biosciences Inc (Imbed) is a medical device company that develops technologies for imbedding bioactive molecules in wound dressings and surgical implants. The company’s polymeric microfilm product platform develops bioactive molecules on tissue surfaces to manage wound infections, biof …
  • Medherant Ltd：医療機器：M&Aディール及び事業提携情報
    Summary Medherant Ltd (Medherant) is a transdermal drug delivery patch company. The company develops and commercializes novel technologies for delivery of drugs through the skin using expertise in bioadhesives and polymer chemistry to treat pain, Alzheimer's disease, and for smoking cessation, hormo …
  • Norsk Hydro ASA：戦略・SWOT・企業財務分析
    Norsk Hydro ASA - Strategy, SWOT and Corporate Finance Report Summary Norsk Hydro ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Biosense Webster Inc：企業の製品パイプライン分析2018
    Summary Biosense Webster Inc (Biosense Webster), a subsidiary of Johnson & Johnson, is a medical device company that designs, manufactures and markets cardiac arrhythmias products. The company’s products include ablation catheters, diagnostic catheters and access, ultrasound catheters and 3D cardiac …
  • The Hokkaido Bank Ltd：企業の戦略・SWOT・財務情報
    The Hokkaido Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Hokkaido Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆